TempraMed Technologies Ltd. is a medical device technology company specializing in patent-protected solutions for temperature-sensitive medications. Its primary focus is revolutionizing injectors and storage for medications like insulin by making them smart and temperature-protected, ensuring potency during the 'last mile' from pharmacy to patient. The company's innovative devices, such as the VIVI Cap, combine space-grade thermal insulation, smart heat-absorbing materials, and digital platforms for precise tracking and data sharing among patients, caregivers, and providers. These hassle-free, battery-free solutions serve individuals with chronic conditions, protecting injectables worldwide without maintenance. TempraMed Technologies Ltd. operates in the life sciences sector, with manufacturing in the USA, assembly in Israel, and distribution through major pharmacy, retail, and government networks across regions including Texas, Dubai, and Mumbai. Founded in Israel and listed publicly since 2025, it bridges medical device engineering and digital health to enhance patient safety and medication management.